FIELD: medicine.
SUBSTANCE: invention relates to method for production of neuromuscular relaxant drug for treatment of muscle dystonias, such as blepharospasm, hemifascial spasm, incominant strabismus, distonic torticollis, local muscle spasm in adults. Claimed method includes culturing of Clostridium botulinum strain 501 on nutrient medium, microbial mass separation by microfiltration, purification by gel-permeation chromatography on column filled with sepharose sorption of diethylaminoethyl cellulose, combining with cryoprotectors , followed by sterilization and lyophilization.
EFFECT: simplified method for production of neuromuscular relaxant drug.
1 ex, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICINAL PREPARATION FOR TREATMENT OF MUSCLE DYSTONIA AND METHOD FOR ITS PREPARING | 2002 |
|
RU2206337C1 |
| PREPARATION FOR TREATMENT OF MUSCULAR DYSTONIA FROM TOXIN OF CULTURE CLOSTRIDIUM BOTULINUM AND METHOD FOR ITS PREPARING | 2004 |
|
RU2255761C1 |
| METHOD FOR PREPARING PURIFIED PREPARATION OF BOTULINIC TOXIN TYPE A | 2002 |
|
RU2230325C2 |
| STRAIN OF HYBRID CELLS OF ANIMALS Mus musculus 3F11 - PRODUCER OF MONOCLONAL ANTIBODIES SPECIFIC TO BOTULINUS TOXIN TYPE B | 2014 |
|
RU2566553C1 |
| STRAIN OF HYBRID ANIMAL CELLS Mus musculus 1G7 - PRODUCER OF MONOCLONAL ANTIBODIES SPECIFIC FOR BOTULINUM TOXIN OF TYPE B | 2014 |
|
RU2571208C1 |
| METHOD FOR BOTULINUM TOXIN PRODUCTION | 2014 |
|
RU2627159C2 |
| METHOD OF PRODUCING BOTULINUM TOXIN | 2016 |
|
RU2707255C1 |
| METHOD FOR PURIFYING OF BOTULINUM TOXIN | 2020 |
|
RU2805226C2 |
| METHOD FOR PURIFICATION OF BOTULINUM TOXIN | 2020 |
|
RU2795197C1 |
| PROCESS FOR PREPARING HIGHLY PURE NEUROTOXIC COMPONENT OF BOTULINUM TOXIN AND USES THEREOF | 2014 |
|
RU2663136C2 |
